Showing posts with label Kidney disease. Show all posts
Showing posts with label Kidney disease. Show all posts

Monday, June 8, 2026

Phosphorus Repletion: Products and their Electrolytes

Monitoring and balancing electrolytes seems to be an inevitable daily function of physicians and other healthcare professionals in the internal medicine and intensive care settings.  Sodium, potassium, magnesium, calcium, and phosphorus seem to constantly need attention when a patient is ill in the hospital (and also because you're checking them every day, sometimes with and sometimes without good reason).  

Tuesday, May 5, 2026

Heart Failure with Preserved Ejection Fraction - Managing Comorbidities

Heart failure (HF) is a complex condition characterized by signs of volume overload or symptoms such as dyspnea, exercise intolerance, and fatigue. Being a syndrome, HF is not explained by one unifying pathophysiologic cause.  Rather, various mechanisms lead to the deficit between the amount of blood delivered and the amount of blood that needs to be delivered through the body to maintain homeostasis.  HF is defined as the previously mentioned signs or symptoms being caused by structural or functional cardiac abnormalities plus either 1) elevated natriuretic peptides (e.g., BNP) or 2) objective evidence of

Monday, October 22, 2018

Sulfamethoxazole/trimethoprim and increase in serum creatinine: When to be concerned

A 65 year old male is being treated for an infection on his forearm that developed purulent drainage within the last few days.  He denies experiencing any penetrating trauma to his arm and denies any other complaints at this time.  He weighs 70 kg, His WBC count is 14.7 x 109/L, serum creatinine is 1.3 mg/dL, and his vital signs are within normal limits.  His past medical history includes hypertension and an MRSA infection last year.  He is currently taking valsartan 160 mg daily and chlorthalidone

Sunday, September 23, 2018

"How it works" series: Midodrine

Midodrine is a peripherally-acting selective alpha1 receptor agonist.  Let's take that sentence apart to see what we should expect from this medication.  Being an alpha1 agonist, this means that it binds to the alpha1 receptor and activates it, causing it to perform the function that it would usually perform if its endogenous catecholamine (ie. norepinephrine) were to bind to it. 

Sunday, September 9, 2018

Nitrofurantoin in renal impairment

A 74 year old female patient presents to clinic describing dysuria and urinary frequency that started within the last few days.  She has no vaginal discharge or irritation and has no CVA tenderness, fevers, chills, flank pain, nausea, or vomiting.  The diagnosis of uncomplicated UTI is made based on clinical suspicion and you decide to prescribe some antibiotics.  She weighs 72 kg and her SCr is 1.4 mg/dL.  Using the Cockcroft-Gault equation,

Monday, October 10, 2016

Metformin in kidney dysfunction - restriction revised

Metformin is the preferred initial pharmacologic therapy in every patient with type 2 diabetes mellitus who does not have a contraindication or intolerance.  It is recommended as monotherapy after diagnosis, continued when adding other medications (including insulin regimens), and should even be considered to prevent diabetes in certain patients (see who at the bottom).  


Old labeling

From approval, the restriction on metformin related to kidney function was as follows

Recommended for you